BRIEF-Nautilus Biotechnology Inc - Quarterly Net Loss Per Share $0.11 - Filing

Reuters10-28

Oct 28 (Reuters) - Nautilus Biotechnology Inc NAUT.O:

NAUTILUS BIOTECHNOLOGY INC - QTRLY NET LOSS PER SHARE $0.11 - FILING
NAUTILUS BIOTECHNOLOGY INC - EXPECT TO LAUNCH EARLY ACCESS PROGRAM WITH TAU PROTEOFORMS IN THE FIRST HALF OF 2026

Source text: [ID:n0001808805-25-000077]

Further company coverage: NAUT.O

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2578329909?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-28 18:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2578329909","market":"us","top_or_hot":-1,"title":"BRIEF-Nautilus Biotechnology Inc - Quarterly Net Loss Per Share $0.11 - Filing","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Nautilus Biotechnology Inc - Quarterly Net Loss Per Share $0.11 - Filing</title></head><body><p><span>Oct 28 (Reuters)</span><span> - </span>Nautilus Biotechnology Inc <span>NAUT.O</span>:</p><ul><li><p>NAUTILUS BIOTECHNOLOGY INC - QTRLY NET LOSS PER SHARE $0.11 - FILING</p></li><li><p>NAUTILUS BIOTECHNOLOGY INC -  EXPECT TO LAUNCH EARLY ACCESS PROGRAM WITH TAU PROTEOFORMS IN THE FIRST HALF OF 2026</p></li></ul><p>Source text: [ID:n0001808805-25-000077]</p><p>Further company coverage: <span>NAUT.O</span></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Nautilus Biotechnology Inc - Quarterly Net Loss Per Share $0.11 - Filing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Nautilus Biotechnology Inc - Quarterly Net Loss Per Share $0.11 - Filing\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-28 18:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Nautilus Biotechnology Inc - Quarterly Net Loss Per Share $0.11 - Filing</title></head><body><p><span>Oct 28 (Reuters)</span><span> - </span>Nautilus Biotechnology Inc <span>NAUT.O</span>:</p><ul><li><p>NAUTILUS BIOTECHNOLOGY INC - QTRLY NET LOSS PER SHARE $0.11 - FILING</p></li><li><p>NAUTILUS BIOTECHNOLOGY INC -  EXPECT TO LAUNCH EARLY ACCESS PROGRAM WITH TAU PROTEOFORMS IN THE FIRST HALF OF 2026</p></li></ul><p>Source text: [ID:n0001808805-25-000077]</p><p>Further company coverage: <span>NAUT.O</span></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NAUT","symbol_name":"Nautilus Biotechnolgy, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nFWN3W90UL:1","article_id":"2578329909","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2578329909","pubTimestamp":1761646954,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Nautilus Biotechnology Inc - Quarterly Net Loss Per Share $0.11 - FilingOct 28  - Nautilus Biotechnology Inc NAUT.O:NAUTILUS BIOTECHNOLOGY INC - QTRLY NET LOSS PER SHARE $0.11 - FILINGNAUTILUS BIOTECHNOLOGY INC -  EXPECT TO LAUNCH EARLY ACCESS PROGRAM WITH TAU PROTEOFORMS IN THE FIRST HALF OF 2026Source text: [ID:n0001808805-25-000077]Further company coverage: NAUT.O","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NAUT":"Nautilus Biotechnolgy, Inc.","BK4121":"生命科学工具和服务"},"translate_title":"简介-Nautilus Biotechnology Inc-季度每股净亏损0.11美元-备案","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NAUT":0.9},"content_text":"BRIEF-Nautilus Biotechnology Inc - Quarterly Net Loss Per Share $0.11 - FilingOct 28 (Reuters) - Nautilus Biotechnology Inc NAUT.O:NAUTILUS BIOTECHNOLOGY INC - QTRLY NET LOSS PER SHARE $0.11 - FILINGNAUTILUS BIOTECHNOLOGY INC -  EXPECT TO LAUNCH EARLY ACCESS PROGRAM WITH TAU PROTEOFORMS IN THE FIRST HALF OF 2026Source text: [ID:n0001808805-25-000077]Further company coverage: NAUT.O","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2578329909","isCrawlerRequest":true}